Chemoinformaics analysis of 4-((E)-3,3-dimethylpenta-1,4-dienyl)-phenol
| Molecular Weight | 188.27 | nRot | 3 |
| Heavy Atom Molecular Weight | 172.142 | nRig | 8 |
| Exact Molecular Weight | 188.12 | nRing | 1 |
| Solubility: LogS | -3.431 | nHRing | 0 |
| Solubility: LogP | 4.026 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 33.1807 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.718 |
| Synth | 2.755 |
| Natural Product Likeliness | 1.273 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.126 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.553 |
| MDCK | 0.0000293 |
| BBB | 0.217 |
| PPB | 0.962793 |
| VDSS | 1.821 |
| FU | 0.0217642 |
| CYP1A2-inh | 0.897 |
| CYP1A2-sub | 0.308 |
| CYP2c19-inh | 0.736 |
| CYP2c19-sub | 0.323 |
| CYP2c9-inh | 0.545 |
| CYP2c9-sub | 0.923 |
| CYP2d6-inh | 0.911 |
| CYP2d6-sub | 0.815 |
| CYP3a4-inh | 0.627 |
| CYP3a4-sub | 0.35 |
| CL | 4.637 |
| T12 | 0.769 |
| hERG | 0.026 |
| Ames | 0.006 |
| ROA | 0.063 |
| SkinSen | 0.943 |
| Carcinogencity | 0.161 |
| EI | 0.991 |
| Respiratory | 0.821 |
| NR-Aromatase | 0.079 |
| Antiviral | Yes |
| Prediction | 0.694484 |